![Mark Bach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Bach
Plus aucun poste en cours
Fortune : 56 644 $ au 31/05/2026
Profil
Le Dr Mark A. Bach, MD, est vice-président principal chargé du développement clinique chez Ascendis Pharma A/S. Auparavant, le Dr Bach a occupé les postes de directeur général chez Accumulus Synergy, Inc, de responsable des sciences médicales pour la région Asie-Pacifique chez Janssen Pharmaceuticals, Inc, de vice-président de la recherche et du développement chez Janssen Pharmaceutical KK, et de vice-président des opérations de recherche clinique au niveau mondial chez Merck & Co, Inc. Il a obtenu son diplôme de premier cycle au Carleton College, un doctorat à l'Université de Chicago et un doctorat au Baylor College of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 4 320 ( 0 % ) | 56 644 $ | 31/05/2026 |
Anciens postes connus de Mark Bach
| Sociétés | Poste | Fin |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 18/09/2024 |
Accumulus Synergy, Inc
 Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Directeur Général | 01/10/2020 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/08/2019 |
Janssen Pharmaceutical KK
 Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/11/2012 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2010 |
Formation de Mark Bach
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Janssen Pharmaceutical KK
Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Health Technology |
Carleton College
 Carleton College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Accumulus Synergy, Inc
Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Commercial Services |
